cyclohexanol has been researched along with Agoraphobia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cassano, GB; Mula, M; Pini, S; Preve, M | 1 |
| Emilien, G; Gao, B; Koponen, H; Lepola, U; Pollack, MH; Salinas, E; Simon, NM; Tzanis, E; Whitaker, T; Worthington, JJ | 1 |
| Coupland, NJ | 1 |
| Anghelescu, I; Himmerich, H; Klawe, C; Szegedi, A | 1 |
1 trial(s) available for cyclohexanol and Agoraphobia
| Article | Year |
|---|---|
A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
Topics: Adult; Agoraphobia; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Panic Disorder; Paroxetine; Personality Inventory; Psychometrics; Quality of Life; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
3 other study(ies) available for cyclohexanol and Agoraphobia
| Article | Year |
|---|---|
Venlafaxine in somatopsychic and autopsychic depersonalization.
Topics: Agoraphobia; Cyclohexanols; Depersonalization; Depressive Disorder; Humans; Male; Obsessive Behavior; Panic Disorder; Paroxetine; Retreatment; Selective Serotonin Reuptake Inhibitors; Trimipramine; Venlafaxine Hydrochloride; Young Adult | 2011 |
Combined antidepressants and CBT for panic disorder with agoraphobia.
Topics: Adult; Agoraphobia; Antidepressive Agents; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Female; Humans; Panic Disorder; Venlafaxine Hydrochloride | 2008 |
Topiramate in venlafaxine-induced visual hallucinations in an obese patient with a posterior cerebral artery infarction.
Topics: Agoraphobia; Alcoholism; Cyclohexanols; Depressive Disorder; Female; Fructose; Hallucinations; Humans; Infarction, Posterior Cerebral Artery; Middle Aged; Neuroprotective Agents; Obesity; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Topiramate; Venlafaxine Hydrochloride | 2001 |